News & Publications for:

Anne Fagan

Preclinical Alzheimer’s disease and its outcome: A longitudinal cohort study

Posted on September 26, 2013

Vos SJB, Xiong C, Visser PJ, Jasielec MS, Hassenstab J, Grant EA, Cairns NJ, Morris JC, Holtzman DM, Fagan AM; (2013) The Lancet Neurology, 12 (10), pp. 957-965. Read More

Posted in: HPAN, Publications Faculty: , , ,

The PSEN1, p.E318G Variant Increases the Risk of Alzheimer’s Disease in APOE-ε4 Carriers

Posted on September 11, 2013

Benitez BA, Karch CM, Cai Y, Jin SC, Cooper B, Carrell D, Bertelsen S, Chibnik L, Schneider JA, Bennett DA, Fagan AM, Holtzman D, Morris JC, Goate AM, Cruchaga C; (2013) PLoS Genetics, 9 (8), art. no. e1003685. Read More

Posted in: Axon Injury & Repair, HPAN, Neurodegeneration, Neurogenetics, Publications Faculty: , , , , ,

Preclinical Alzheimer disease and risk of falls

Posted on August 29, 2013

Stark SL, Roe CM, Grant EA, Hollingsworth H, Benzinger TL, Fagan AM, Buckles VD, Morris JC; (2013) Neurology, 81(5), pp. 437-443. Read More

Posted in: HPAN, Publications Faculty: ,

Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.

Posted on July 23, 2013

Richard J. Perrin,Jacqueline E. Payton, James P. Malone, Petra Gilmore, Alan E. Davis, Chengjie Xiong, Anne M. Fagan, R. Reid Townsend, and David M. Holtzman,
Dulce Elena Casarini, Editor; PLoS One. 2013; 8(5): e64314.Published online 2013 May 20. doi: 10.1371/journal.pone.0064314
Read More

Posted in: HPAN, Publications Faculty: , ,